MEGAMONT-L
MEGAMONT-L Allergy Control
Respiratory allergy prophylaxis
Key Composition
- Montelukast 10 mg + Levocetirizine 5 mg once-daily dosing
- Sugar-free coating suitable for diabetic patients
- Reduces nocturnal sneezing and exercise-induced triggers
Why Prescribers Choose MEGAMONT-L
MEGAMONT-L delivers effective control over chronic allergic rhinitis and asthma symptoms. The synergistic action of Montelukast and Levocetirizine provides 24-hour relief from congestion, runny nose, and allergic coughing.
How to Recommend
- Prescribe one tablet daily in the evening to match the body's natural histamine cycle.
- Advise patients to continue the course even if symptoms are mild, to prevent recurrence.
- Safe for long-term management of seasonal allergies.